Article thumbnail
Location of Repository

The Transforming Growth Factor-β Pathway Is a Common Target of Drugs That Prevent Experimental Diabetic Retinopathy

By Chiara Gerhardinger, Zeina Dagher, Paola Sebastiani, Yong Seek Park and Mara Lorenzi
Topics: Original Article
Publisher: American Diabetes Association
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat.
  2. (1996). Accelerated death of retinal microvascular cells in human and experimental diabetic retinopathy.
  3. (2009). actin polymerization by WASp causes defects of mitosis and cytokinesis in X-linked neutropenia.
  4. Activation of nuclear factor-B induced by diabetes and high glucose regulates a proapoptotic program in retinal pericytes.
  5. Activation of transforming growth factor- signaling by SUMO-1 modification of tumor suppressor Smad4/DPC4.
  6. (2005). Aldose reductase in microvascular complications. Curr Drug Targets
  7. Aldose reductase inhibition counteracts oxidative-nitrosative stress and poly(ADP-ribose) polymerase activation in tissue sites for diabetes complications.
  8. (1998). An aldose reductase inhibitor prevents glucoseinduced increase in transforming growth factor- and protein kinase C activity in cultured human mesangial cells. Diabetologia
  9. Angiotensin II blockade and aortic-root dilation in Marfan’s syndrome.
  10. AP-1 proteins mediate hyperglycemia-induced activation of the human TGF-1 promoter in mesangial cells.
  11. (2005). Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects. Diabetes
  12. (2006). Bone morphogenetic protein-2 modulates Wnt and frizzled expression and enhances the canonical pathway of Wnt signaling in normal keratinocytes.
  13. Cathepsin B regulates the intrinsic angiogenic threshold of endothelial cells.
  14. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.
  15. deficiency increases tubular damage but reduces renal fibrosis in obstructive nephropathy.
  16. Diabetic retinopathy: a clinical overview. Diabetes Care 1992;15:
  17. Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina.
  18. Differential gene expression in pulmonary artery endothelial cells exposed to sickle cell plasma.
  19. Early complement activation and decreased levels of glycosylphosphatidylinositol-anchored complement inhibitors in human and experimental diabetic retinopathy.
  20. Emilin1 links TGF- maturation to blood pressure homeostasis.
  21. Expression of acute-phase response proteins in retinal Mu ¨ller cells in diabetes.
  22. (1998). Expression of vascular endothelial growth factor in the human retina and in nonproliferative diabetic retinopathy.
  23. Gru ¨ndemann D, Scho ¨mig E. Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action.
  24. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein.
  25. Identification of a series of transforming growth factor -responsive genes by retrovirusmediated gene trap screening.
  26. IGF-I mRNA and signaling in the diabetic retina.
  27. (1994). Increased expression of basement membrane collagen in human diabetic retinopathy.
  28. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress.
  29. Long-term prevention of renal insufficiency excess matrix gene expression and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor- antibody in db/db diabetic mice.
  30. (2006). Mechanisms and strategies for prevention in diabetic retinopathy. Curr Diab Rep
  31. (2007). Metabolic memory phenomenon and accumulation of peroxynitrate in retinal capillaries. Exp Diabetes Res
  32. Molecules mimicking Smad1 interacting with Hox stimulate bone formation.
  33. (1998). Mu ¨ller cell changes in human diabetic retinopathy. Diabetes
  34. New insights into TGF--Smad signaling.
  35. Nitric oxide induces TIMP-1 expression by activating the transforming growth factor -Smad signaling pathway.
  36. Non-Smad TGF- signals.
  37. Oncofetal fibronectin in diabetic retinopathy.
  38. Pharmacological inhibition of diabetic retinopathy: aminoguanidine and aspirin.
  39. Poly(ADP-ribose) polymerase is involved in the development of diabetic retinopathy via regulation of nuclear factor-B.
  40. Reducing endogenous tau ameliorates amyloid -induced deficits in an Alzheimer’s disease mouse model.
  41. Roles of connective tissue growth factor and prostanoids in early streptozotocin-induced diabetic rat kidney: the effect of aspirin treatment.
  42. Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors.
  43. Significance analysis of microarrays applied to the ionizing radiation response.
  44. Sjølie AK; DIRECT Programme Study Group. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.
  45. (2009). SM16 an orally active TGF- type I receptor inhibitor prevents myofibroblast induction and vascular fibrosis in the rat carotid injury model. Arterioscler Thromb Vasc Biol 2008;28:665–671 C.
  46. Studies of rat and human retinas predict a role for the polyol pathway in human diabetic retinopathy.
  47. Syndecan-2 regulates transforming growth factor- signaling.
  48. TGF- signaling and the fibrotic response.
  49. TGF--induced apoptosis is mediated by the adapter protein Daxx that facilitates JNK activation.
  50. The Edg family G protein-coupled receptors for lysophospholipids: their signaling properties and biological activities.
  51. The Writing Team for the Diabetes Control and Complications Trial/ Epidemiology of Diabetes Interventions and Complications Research Group: Effect of intensive therapy on the microvascular complications of type 1 diabetes mellitus.
  52. (2005). Vascular injury induces expression of periostin: implications for vascular cell differentiation and migration. Arterioscler Thromb Vasc Biol
  53. VDUP1 upregulated by TGF-1 and 125-dihydroxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.